retatrutide update october 2025 Timeline: Week-by-Week Results (48 Weeks) Retatrutide UK Guide: Key Facts

FDA has issued a box warning of the risk of thyroid cancers and are contraindicated liraglutide, exenatide (once weekly), and semaglutide (both oral and injectable) in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia types 2 A or 2B [135, 136]

One is that when glucose levels are high, they trigger the pancreas to release insulin and suppress glucagon, which helps lower your blood sugar levels

Users who establish solid dietary and activity habits during treatment may experience somewhat less regain, though none are fully protected from metabolic rebound

Telehealth solves this

Mazdutide leads in overall clinical evidence maturity with Phase 3 completion, regulatory approval, and head-to-head superiority data versus semaglutide

Berberine shows modest evidence of supporting GLP-1 secretion and weight management, but it acts differently than GLP-1 medications, carries risks, including drug interactions, and should only be taken under the guidance of a licensed healthcare provider